Raleigh, North Carolina (January 12, 2026) — Spring & Mulberry is voluntarily recalling lot #025255 of its Mint Leaf Date Sweetened Chocolate Bar (2.1 oz) due to possible contamination with Salmonella.
Similar Posts
IntegraDose Compounding Services LLC. Minneapolis, MN. 483 issued 07/25/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 07/25/2025
Short Title (70 char) IntegraDose Compounding Services LLC. Minneapolis, MN. 483 issued 07/25/2025
FEI Number 3014483112
Firm Name IntegraDose Compounding Services LLC
Record Type 483
State MN
EstabliRisk of False Positive Lead Test Results with Certain Capillary Blood Collection Tubes Used with Magellan Diagnostics LeadCare Testing Systems – FDA Safety Communication
FDA is alerting health care providers and lab staff of reports of false positives when using certain Micro Capillary Blood Collection tubes with the LeadCare Testing Systems.Reviews of Pediatric Studies Conducted under BPCA and Pediatric assessments conducted under PREA from 2012 – present
The following are the medical, statistical, and clinical pharmacology reviews of pediatric studies conducted in response to a Written Request issued under the BPCA and pediatric assessments conducted under PREA.FDA Approves First Treatment for Children With Menkes Disease
The U.S. Food and Drug Administration today approved the Zycubo (copper histidinate) injection as the first treatment for Menkes disease in pediatric patients.Tri-Union Seafoods Identifies Additional Quantities of Recalled Genova® Tuna at Limited Retailers Due to Inadvertent Distribution of Previously Recalled Product
El Segundo, CA, January 16, 2026 – Tri-Union Seafoods is cautioning consumers that a third-party distributor inadvertently released quarantined product that was associated to a February 2025 recall. The initial voluntary recall was conducted following notification from our supplier that the “easy opAbout CDER Small Business and Industry Assistance (SBIA)
CDER Small Business and Industry Assistance (SBIA) helps small pharmaceutical business and industry navigate the wealth of information that FDA offers, and provides assistance in understanding the regulation of human drug products.